Bone Marrow Transplantation

Title Publication Date Language Citations
The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Nurses Group – Poster Sessions (NP001-NP041)2023/11/01English
Comparison of MEAM, MCEC and LEED high-dose chemotherapy followed by autologous stem cell transplantation in relapsed/refractory diffuse large B-cell lymphoma: data from the Japan Society for Hematopoietic and Cellular Therapy Registry2023/10/07English
Prevalence, management, and new treatment modalities of EBV-DNA-emia and EBV-PTLD after allo-HCT: survey of Infectious Diseases Working Party EBMT2023/10/23English
Transplant conditioning with bortezomib, thalidomide, and melphalan and intensive 2 year post-transplant therapy for multiple myeloma in older patients2023/10/10English
Low incidence of engraftment syndrome following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide2023/10/11English
The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Welcome Address2023/11/01English
The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Data Management Group – Poster Session (P725-P741)2023/11/01English
Hematopoietic stem cell transplantation in patients with Fanconi anemia: a report of late effects and psychosocial adjustment in life2023/10/25English
The effect of danger-associated molecular patterns on survival in acute graft versus host disease2023/11/07English
AKI treated with kidney replacement therapy in critically Ill allogeneic hematopoietic stem cell transplant recipients2023/11/07English
Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease: a randomized phase 2 trial2023/11/04English
A novel flow-cytometric based method to assess post-HSCT donor chimerism exploiting RNA hybridization2023/11/07English
CALR mutations possess unique prognostic relevance in myelofibrosis—before and after transplant2023/10/11English
Storage of wine and blood2024/03/21English
Improving nutritional status after allogeneic stem cell transplantation: results of phase 2 ALLONUT clinical trial2024/03/20English
Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire2024/03/21English
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease2024/03/14English
Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT2024/03/19English
Pulmonary function as a continuum of risk: critical care utilization and survival after allogeneic hematopoietic stem cell transplantation - a multicenter cohort study2024/03/16English
Long term outcomes of nonmyeloablative allogeneic stem cell transplantation with TSEB TLI and ATG for Mycosis Fungoides and Sezary Syndrome2024/03/12English
EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation2024/03/23English
Improving the EASIX’ predictive power for NRM in adults undergoing allogeneic hematopoietic cell transplantation2024/03/23English
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT2024/03/15English
Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in Germany2024/03/14English
A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome2024/03/27English
Ruxolitinib in patients with graft versus host disease (GvHD): findings from a compassionate use program2024/02/15English
Changing landscapes2023/02/16English
Graft-versus-host disease-free, relapse-free, second transplant-free survival in allogeneic hematopoietic cell transplantation for genetic disorders2023/02/16English
Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation2023/02/16English
Relapsed systemic light chain amyloidosis – in search of a higher bar2024/01/23English